Find Nonprofit and Small Business Grants

Advance Search

Only Available for Paid Subscribers
Clear Filters
Search Filters

Targeted Research Initiative for Morbidity and Mortality

Grants to USA Medical Researchers for Preliminary
Research to Improve the Lives of People with Epilepsy

Agency Type:

Foundation / Corporation

Funding Source:

Add to My Calendar 

Epilepsy Foundation

Deadline Date:

03/20/15 11:59 PM ET

Description:

Request a Grant Writer

Grants of up to $50,000 to USA individual medical researchers employed at a university, research or medical institution for epilepsy research that generates initial data leading to more extensive projects. The goal of this initiative is to create the basis for more extensive projects that will generate knowledge to ultimately improve the lives of persons with epilepsy.

The broad focus of the morbidity portion of this program includes:

1) Identification of somatic comorbidities in epilepsy that occur more than expected among controls, including but not limited to diabetes, gastrointestinal bleeding, chronic lung disease, congenital cardiac abnormalities, heart failure, and pneumonia; and

2) Associations between somatic comorbidities in epilepsy and epilepsy outcomes, including quality of life in epilepsy, seizure remission, stigma and other outcomes. The mortality portion of the program is focused upon potentially preventable causes of death in epilepsy, such as accidents, suicide and SUDEP.

Applicants are encouraged to examine risk factors for these causes of death in epilepsy; as well as interventions to decrease the presence of risk factors for these causes of death where risk factors have been identified.

Grant funds may be used for salary support for personnel directly engaged in the project, consumable supplies and services, and travel essential to the conduct of the research.

GrantWatch ID#:

GrantWatch ID#: 150970

Estimated Size of Grant:

Up to $50,000.

Term of Contract:

The maximum grant term is one year beginning July 1, 2015.

Additional Eligibility Criteria:

To be eligible to apply for a grant, an applicant must:

1) Hold a Master of Science, Doctor of Medicine, Doctor of Philosophy, Doctor of Science, or equivalent degree. The eligibility of people holding other doctoral level degrees (ex. PharmD) may be considered by the Foundation’s Research Council based on the merit of the research proposal; and

2) Have an academic appointment in a university or medical school, or equivalent standing at a research institution or medical center. Postdoctoral fellows must be at least in the second year of fellowship with an active academic appointment by the start of this grant. Those in non-academic settings with equivalent positions must demonstrate equivalence of appointment through a letter of explanation.

These grants are intended for those who conduct independent research, and are not intended for those seeking a research training experience. Visit the Foundation’s Website to find research training fellowships at: http://www.epilepsyfoundation.org/research/grants.cfm

Applicants whose research will involve patient care or direct involvement with patients must have completed all residency training and be licensed to practice medicine at their institution. US citizenship is not required, but the research must be conducted in the US. Institutional Review Board (IRB) approval is necessary.

Grant funds may NOT be used for indirect costs or institutional overhead, and the purchase of permanent equipment that exceeds 10% of the budget without prior approval.

Pre-Application Information:

Apply online here: https://proposalcentral.altum.com/

An applicant may not apply for, use or accept funds for a research project or part of a project already supported by funds from any public or private source. Accordingly, full disclosure of all available and pending funds for research support must be made in the grant application.

If funds from other sources become available to the applicant during the review or tenure of a research grant awarded through this program, the Principal Investigator must inform the Foundation in writing. An administrative decision will then be made about the continuation of the research award.

All applications are due by March 20, 2015 for funding to begin July 1, 2015. A complete application must be submitted via the proposalCentral system by 11:59 p.m. Eastern time on March 20, 2015. The proposalCentral system can be accessed at: https://www.proposalcentral.altum.com

A proposalCENTRAL helpline is available for questions from applicants during normal business hours (8:30 a.m. – 5:00 p.m.), Monday-Friday, EST. Phone: 1-800-875-2562 (toll-free) or 1-703-964-5840 (international) and pcsupport@altum.com.

Award funds are paid to the recipient’s institution or company in quarterly payments over the term of the award. Continued funding is contingent upon submission of annual progress and financial reports, and confirmation that appropriate institutional approvals for human subjects and animal use are current and on file at the institution.

Contact Information:

Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.

Technical Support:
1-800-875-2562 (toll-free) / 1-703-964-5840 (international)
pcsupport@altum.com

Kim Macher
kmacher@efa.org

Epilepsy Foundation
8301 Professional Place East, Suite 200
Landover, MD 20785-2353

URL for Full Text (RFP):

Geographic Focus:

USA: Alabama;   Alaska;   Arizona;   Arkansas;   California;   Colorado;   Connecticut;   Delaware;   Florida;   Georgia;   Hawaii;   Idaho;   Illinois;   Indiana;   Iowa;   Kansas;   Kentucky;   Louisiana;   Maine;   Maryland;   Massachusetts;   Michigan;   Minnesota;   Mississippi;   Missouri;   Montana;   Nebraska;   Nevada;   New Hampshire;   New Jersey;   New Mexico;   New York City;   New York;   North Carolina;   North Dakota;   Ohio;   Oklahoma;   Oregon;   Pennsylvania;   Rhode Island;   South Carolina;   South Dakota;   Tennessee;   Texas;   Utah;   Vermont;   Virginia;   Washington, DC;   Washington;   West Virginia;   Wisconsin;   Wyoming